Information Links
Licence Changes & Product Updates

SGLT2 inhibitor approval 'turning point' for underserved heart failure population
Empagliflozin (Jardiance) is the first licensed treatment...

Metformin 'safe in pregnancy', says MHRA
Prescribing advice for metformin in pregnancy has been...

Metered-dose inhaler certified 'carbon-neutral'
Luforbec (beclometasone/formoterol) has been certified...

Sixth COVID-19 vaccine approved in UK
A whole-virus inactivated vaccine developed by Valneva...

Shortages of oestrogen-only HRT reported
'Exceptionally high demand' has resulted in shortages...

Fifth COVID-19 vaccine approved in UK
Nuvaxovid will be considered by the Joint Committee...

Pfizer/BioNTech COVID-19 vaccine approved for paediatric use
A new lower-dose presentation of Comirnaty has been...

Intal asthma inhaler to be discontinued
The asthma preventer inhaler Intal (sodium cromoglicate)...

Dapagliflozin no longer indicated for type I diabetes
Dapagliflozin (Forxiga) should no longer be prescribed...

First oral antiviral for COVID-19 approved in UK
Molnupiravir (Lagevrio) is safe and effective at reducing...